- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel M2e Based Flu Vaccine Formulation for Dogs
Authors
Keywords
Vaccines, Dogs, Immunologic adjuvants, Influenza, Enzyme-linked immunoassays, Immune response, Mouse models, Influenza viruses
Journal
PLoS One
Volume 8, Issue 10, Pages e77084
Publisher
Public Library of Science (PLoS)
Online
2013-10-03
DOI
10.1371/journal.pone.0077084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge
- (2013) Xiao Gao et al. ANTIVIRAL RESEARCH
- Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
- (2013) Cindy Babin et al. JOURNAL OF NANOBIOTECHNOLOGY
- Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
- (2012) Min-Chul Kim et al. MOLECULAR THERAPY
- Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites
- (2012) Gervais Rioux et al. PLoS One
- Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge
- (2012) Hamidreza Hashemi et al. PLoS One
- Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]
- (2012) Christian Savard et al. VACCINE
- Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants
- (2011) Slavica Matić et al. BMC BIOTECHNOLOGY
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
- (2011) Jae-Min Song et al. PLoS One
- Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles
- (2011) Christian Savard et al. PLoS One
- Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
- (2010) Alain C. Tissot et al. PLoS One
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses
- (2010) Andres G. Grandea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes
- (2010) Laïla-Aïcha Hanafi et al. VACCINE
- Influenza A viruses: why focusing on M2e-based universal vaccines
- (2010) Seyyed Mahmoud Ebrahimi et al. VIRUS GENES
- The path to a successful vaccine adjuvant – ‘The long and winding road’
- (2009) Derek T. O’Hagan et al. DRUG DISCOVERY TODAY
- TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens
- (2009) Luisa Cervantes-Barragán et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
- (2009) Tong-Ming Fu et al. VACCINE
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
- (2008) Jérôme Denis et al. VACCINE
- Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
- (2008) Marina De Filette et al. VACCINE
- Nucleotide sequence and phylogenetic analysis of a new potexvirus: Malva Mosaic Virus
- (2007) Fabien Côté et al. INFECTION GENETICS AND EVOLUTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search